Synapsoft logo
AI Insights from Disclosures
Searching...
JEIL PHARMACEUTICAL CO.,LTD 271980
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
JEIL PHARMACEUTICAL CO.,LTD was established as a spin-off, with June 1, 2017 as the demerger date, of the prescription drug business segment of Jeil Pharm Holdings Co., Ltd. (formerly Jeil Pharmaceutical Co., Ltd.), and its principal business is the manufacture and sale of finished pharmaceutical products. Its subsidiary, Onconic Therapeutics Co., Ltd., commenced operations on May 7, 2020, and its principal business is new drug development research and R&D.
Representative Director 성석제, 한상철 (공동대표)
Founded June 1, 2017
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-6420361
Business number 628-88-00669
Phone Number 02-549-7451
Fax Number 02-518-6485
Company Address 343 Sapyeong-daero, Seocho-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant